Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 107

Sort by

Sort Order Select

Journal Articles

Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis

Blood (2021) 137 (15): 2070–2084.

https://doi.org/10.1182/blood.2019004509

Published: 2021

Includes: Supplemental data

Journal Articles

New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

Andreas Reiter, Tracy I. George, Jason Gotlib

Blood (2020) 135 (16): 1365–1376.

https://doi.org/10.1182/blood.2019000932

Published: 2020

Journal Articles

Safety and Utilization of Midline Catheters in the Management of Acute Myeloid Leukemia: A Single Center Experience

Jose Miguel Torregrosa Diaz, Helene Gardeney, Maria Pilar Gallego Hernanz, Deborah Desmier, Xavier Leleu, MD PhD, Blandine Rammaert, MD PhD

Blood (2019) 134 (Supplement_1): 5840.

https://doi.org/10.1182/blood-2019-130884

Published: 2019

Journal Articles

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Nicole Ng, BS, Erin Yu, BS, Sean Bujarski, BA, Zhengyi Yin, Tara Hekmati, Dylan Field, Jasper Wang, Isabella Nassir, Janna Yu, Justin Huang, David Daniely, Cathy S. Wang, BS, Ning Xu, PhD, James R. Berenson, MD

Blood (2019) 134 (Supplement_1): 4402.

https://doi.org/10.1182/blood-2019-130888

Published: 2019

Journal Articles

BCL-2 Is Expressed in Advanced Mastocytosis and Midaustorin Induces Venetoclax Sensitivity of Mast Leukemia Cell Lines

Danielle Canioni, MD, Josquin Moraly, MD, Ludovic Lhermitte, MD PhD, Laura Polivka, MD, Mélanie Féroul, Julien Rossignol, MD PhD, Laurent Frenzel, MD PhD, Michel Arock, pharmD, PhD, Patrice Dubreuil, PhD, Leila maouche-Chretien, PhD, Olivier Hermine, MD PhD

Blood (2019) 134 (Supplement_1): 1683.

https://doi.org/10.1182/blood-2019-131256

Published: 2019

Journal Articles

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

Yankai Zhang, PhD, Celeste K. Kanne, BA, Jennifer N. Tran, DO, Michael J. Lacagnina, PhD, Peter M. Grace, PhD, Vivien A. Sheehan, MD PhD

Blood (2019) 134 (Supplement_1): 3575.

https://doi.org/10.1182/blood-2019-128921

Published: 2019

Journal Articles

Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT 2 receptors

Mohamad Fadhli Bin Masri, Chinmay Kumar Mantri, Abhay P. S. Rathore, Ashley L. St. John

Blood (2019) 133 (21): 2325–2337.

https://doi.org/10.1182/blood-2018-08-869156

Published: 2019

Includes: Supplemental data

Journal Articles

A Retrospective Case Series Describing the Efficacy of Omalizumab in Systemic Mastocytosis

Calum Anthony Slapnicar, Conrad Scullion Smeenk, Lisa K. Hicks, MD MSc, Jessica Petrucci, MSc, Peter Vadas, MD, Martina Trinkaus, MD

Blood (2018) 132 (Supplement 1): 5470.

https://doi.org/10.1182/blood-2018-99-118415

Published: 2018

Journal Articles

A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis

Calum Anthony Slapnicar, Conrad Scullion Smeenk, Lisa K. Hicks, MD MSc, Jessica Petrucci, MSc, Peter Vadas, MD, Martina Trinkaus, MD

Blood (2018) 132 (Supplement 1): 5474.

https://doi.org/10.1182/blood-2018-99-120112

Published: 2018

Journal Articles

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

Aditya M Mittal, Huy Tran, BSMedTech, Varun Sagi, BS, Aithanh Nguyen, Kathryn Luk, Julia Nguyen, BS, Jianxun Lei, PhD, Kalpna Gupta, PhD

Blood (2018) 132 (Supplement 1): 269.

https://doi.org/10.1182/blood-2018-99-117246

Published: 2018

Journal Articles

Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score

Steven T Bird, PhD PharmD, Natasha Flowers, BA, Fang Tian, PhD MHS, MPH, Donna Przepiorka, MD PhD, Tae Hyun Jung, PhD, Rongrong Wang, MPH, Zebulin Kessler, BS, Corinne Woods, RPh, MPH, Bo Kim, BA, Barry W. Miller, MS, CNP, Michael Wernecke, BA, Stephen McKean, PhD, Clara Kim, PhD, Kate Gelperin, MD MPH, Jeffrey A Kelman, MD MMSc, David J Graham, MD MPH

Blood (2018) 132 (Supplement 1): 2889.

https://doi.org/10.1182/blood-2018-99-116498

Published: 2018

Journal Articles

Effects of the Gamma Secretase Inhibitors (GSI) Dapt (GSI-IX) and LSN424354 on Gene Expression and Shedding of Bcma from Multiple Myeloma and Chronic Lymphocytic Leukemia Tumor Cells

Haiming Chen, MD PhD, Mingjie Li, BS, Eric Sanchez, BA, Camilia Soof, BS, Saurabh Patil, BS, Kyle Udd, BA, Mizi Zhou, MS, Tara Hekmati, BS, Emily Y Wang, Edward J Tanenbaum, BS, Remy Schlossberg, Moryel A Yashar, BS, Cathy S Wang, BS, George Y Tang, PhD, James R Berenson, MD

Blood (2017) 130 (Supplement 1): 5390.

https://doi.org/10.1182/blood.V130.Suppl_1.5390.5390

Published: 2017

Journal Articles

Cytokine Profiling of Human Umbilical Cord Plasma and Human Umbilical Cord Blood Mononuclear Cells

Ekaterina E. Garanina, PhD, Dilara Gatina, Ekaterina V. Martynova, MD PhD, Albert Rizvanov, DSc, PhD, Svetlana Khaiboullina, DrSci, MD, Ilnur Salafutdinov, PhD

Blood (2017) 130 (Supplement 1): 4814.

https://doi.org/10.1182/blood.V130.Suppl_1.4814.4814

Published: 2017

Journal Articles

Phase 2 Study of Brentuximab Vedotin in Patients with Advanced Systemic Mastocytosis

John H. Baird, Srdan Verstovsek, MD PhD, Tracy I. George, Isabel Reyes, Justin Abuel, Cecelia Perkins, Cheryl Langford, Kurt Schroeder, Jason Gotlib, MD

Blood (2017) 130 (Supplement 1): 2909.

https://doi.org/10.1182/blood.V130.Suppl_1.2909.2909

Published: 2017

Journal Articles

Enolase 2-Mediated Glucose Metabolism Promotes Cell Proliferation and Survival in Acute Lymphoblastic Leukemia

Liu Chengcheng, Wang Hua, Wang Weida, Liu Wenjian, Lu Yue

Blood (2017) 130 (Supplement 1): 5124.

https://doi.org/10.1182/blood.V130.Suppl_1.5124.5124

Published: 2017

Journal Articles

Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells

Manuela Mancini, PhD, Cecilia Monaldi, Sara De Santis, Cristina Papayannidis, MD, Michela Rondoni, MD, Maria Chiara Abbenante, MD, Luana Bavaro, Margherita Martelli, Roberta Zanotti, MD, Livio Pagano, MD, Michele Cavo, MD, Peter Valent, MD, Giovanni Martinelli, MD, Simona Soverini, PhD

Blood (2017) 130 (Supplement 1): 5290.

https://doi.org/10.1182/blood.V130.Suppl_1.5290.5290

Published: 2017

Journal Articles

Mast Cell Leukemia: Clinical Heterogeneity, Molecular Aberrations, Treatment Responses, Survival, and Prognostic Factors

Mohamad Jawhar, MD, Juliana Schwaab, MD, Manja Meggendorfer, PhD, Nicole Naumann, Hans-Peter Horny, MD, Karl Sotlar, MD, Torsten Haferlach, MD, Karla Schmitt, MD, Alice Fabarius, PhD, Peter Valent, MD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Georgia Metzgeroth, MD, Andreas Reiter, MD

Blood (2016) 128 (22): 3109.

https://doi.org/10.1182/blood.V128.22.3109.3109

Published: 2016

Journal Articles

Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti-Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo

Eric Sanchez, BA, Mingjie Li, BS, Cathy S Wang, BS, Puja Mehta, BS, George Tang, PhD, Haiming Chen, MD PhD, James Berenson, MD

Blood (2016) 128 (22): 3297.

https://doi.org/10.1182/blood.V128.22.3297.3297

Published: 2016

Journal Articles

Characterization of Mast Cell Activation Syndrome

Lawrence B Afrin, MD, Sally Self, MD, Jeremiah Menk, M.S., John Lazarchick, MD

Blood (2016) 128 (22): 3683.

https://doi.org/10.1182/blood.V128.22.3683.3683

Published: 2016

Journal Articles

Inhibitory Effects of Midostaurin and Blu-285 on Myeloid Progenitor Cells Derived from Patients with Multi-Mutated KIT D816V+ Advanced Systemic Mastocytosis

Mohamad Jawhar, MD, Nicole Naumann, Sebastian Kluger, Juliana Schwaab, MD, Georgia Metzgeroth, MD, Erica K. Evans, PhD, Alexandra Gardino, PhD, Christoph Lengauer, PhD, Wolf-Karsten Hofmann, MD, Nicholas C.P. Cross, PhD, Alice Fabarius, PhD, Andreas Reiter, MD

Blood (2016) 128 (22): 1964.

https://doi.org/10.1182/blood.V128.22.1964.1964

Published: 2016

NARROW

Nintedanib targets KIT D816V neoplastic cells derived from induced pluripotent stem cells of systemic mastocytosis

New developments in diagnosis, prognostication, and treatment of advanced systemic mastocytosis

Safety and Utilization of Midline Catheters in the Management of Acute Myeloid Leukemia: A Single Center Experience

Ruxolitinib Reverses Checkpoint Inhibition By Downregulating PD-L1 and PD-L2 Expression on Both Tumor and Stromal Cells in Multiple Myeloma

BCL-2 Is Expressed in Advanced Mastocytosis and Midaustorin Induces Venetoclax Sensitivity of Mast Leukemia Cell Lines

Microglia-like Cells Derived from Hematopoietic Stem and Progenitor Cells Are a Model System to Investigate Chronic Pain in Sickle Cell Disease

Peripheral serotonin causes dengue virus–induced thrombocytopenia through 5HT 2 receptors

A Retrospective Case Series Describing the Efficacy of Omalizumab in Systemic Mastocytosis

A Retrospective Case Series Describing the Efficacy of Ketotifen in Systemic Mastocytosis

Mast Cells Contribute to Brain Microvascular Permeability in Sickle Cell Disease

Idelalisib for Treatment of Follicular Lymphoma and Chronic Lymphocytic Leukemia in Clinical Trials Versus the Real World: Treatment Duration and Survival Are Associated with Pretreatment Modified Charlson Score

Effects of the Gamma Secretase Inhibitors (GSI) Dapt (GSI-IX) and LSN424354 on Gene Expression and Shedding of Bcma from Multiple Myeloma and Chronic Lymphocytic Leukemia Tumor Cells

Cytokine Profiling of Human Umbilical Cord Plasma and Human Umbilical Cord Blood Mononuclear Cells

Phase 2 Study of Brentuximab Vedotin in Patients with Advanced Systemic Mastocytosis

Enolase 2-Mediated Glucose Metabolism Promotes Cell Proliferation and Survival in Acute Lymphoblastic Leukemia

Polo-like Kinase-1 and Aurora Kinase A As Novel Therapeutic Targets in Neoplastic Mast Cells

Mast Cell Leukemia: Clinical Heterogeneity, Molecular Aberrations, Treatment Responses, Survival, and Prognostic Factors

Effects of INCB052793, a Selective JAK1 Inhibitor, in Combination with Anti-Myeloma Agents on Human Multiple Myeloma (MM) In Vitro and In Vivo

Characterization of Mast Cell Activation Syndrome

Inhibitory Effects of Midostaurin and Blu-285 on Myeloid Progenitor Cells Derived from Patients with Multi-Mutated KIT D816V+ Advanced Systemic Mastocytosis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only